CHOSA Oncology AB Logo

CHOSA Oncology AB

CHOSA | SPGR

Overview

Corporate Details

ISIN(s):
SE0007784319
LEI:
5493002SFL9YXB0A0027
Country:
Sweden
Address:
C/O Medicon Village, C/O Medicon Village, Scheeletorget 1, 223 81 Lund
Sector:
Health Care
Industry:
Biotechnology

Description

Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioPorto Logo BioPorto Denmark BIOPOR
BioSenic SA Logo BioSenic SA Belgium BIOS
Biosergen AB Logo Biosergen AB Sweden BIOSGN
BIOTECH Logo BIOTECH Spain BST
Biotest AG Logo Biotest AG Germany BIO3
Bioton S.A. Logo Bioton S.A. Poland BIO
Bioversys N Logo Bioversys N Switzerland BIOV
Biovica International B Logo Biovica International B Sweden BIOVIC
Bonus BioGroup Ltd. Logo Bonus BioGroup Ltd. Israel BONS
BRAIN Biotech AG Logo BRAIN Biotech AG Germany BNN